Advertisement

Cribriform-Morular Variant of Papillary Thyroid Carcinoma

  • Ayana SuzukiEmail author
  • Mitsuyoshi Hirokawa
  • Nami Takada
Chapter

Abstract

Cribriform-morular variant of papillary thyroid carcinoma (CMV-PTC) is rare and constitutes less than 0.5% of all PTC. CMV-PTC typically affects young adults with a female predominance, showing a female-to-male ratio of 17:1. It is commonly associated with familial adenomatous polyposis and has a germline mutation in the adenomatous polyposis coli (APC) gene. However, sporadic form without FAP has been also reported. Preoperative diagnosis of CMV-PTC is important. As CMV-PTC with FAP usually displays multifocal nodules, total thyroidectomy is required. On the other hand, lobectomy is sufficient for sporadic cases because of solitary nodule and excellent prognosis. In this chapter, we describe the diagnostic clue of CMV-PTC.

References

  1. 1.
    Nikiforov YE. Diagnostic pathology and molecular genetics of the thyroid: a comprehensive guide for practicing thyroid pathology. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 191–2.Google Scholar
  2. 2.
    Harach HR, Williams GT, Williams ED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathol. 1994;25:549–61.CrossRefGoogle Scholar
  3. 3.
    Cetta F, Toti P, Petracci M, et al. Thyroid carcinoma associated with familial adenomatous polyposis. Histopathol. 1997;31:231–6.CrossRefGoogle Scholar
  4. 4.
    Rosai J, Albores Saavedra J, Asioli S, et al. Papillary tyroid carcinoma. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J, editors. World Health Organization Classification of tumours of endocrine organs. 4th ed. Lyon: IARC; 2017. p. 87.Google Scholar
  5. 5.
    Lam AK, Saremi N. Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer. Endocr Relat Cancer. 2017;24:R109–21.CrossRefGoogle Scholar
  6. 6.
    Kini SR. Thyroid cytopathology: an Atlas and text. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 163–9.Google Scholar
  7. 7.
    Hirokawa M, Maekawa M, Kuma S, et al. Cribriform-morular variant of papillary thyroid carcinoma—cytological and immunocytochemical findings of 18 cases. Diagn Cytopathol. 2010;38:890–6.CrossRefGoogle Scholar
  8. 8.
    Koo JS, Jung W, Hong SW. Cytologic characteristics and β-catenin immunocytochemistry on smear slide of cribriform-morular variant of papillary thyroid carcinoma. Acta Cytol. 2011;55:13–8.CrossRefGoogle Scholar
  9. 9.
    Kuma S, Hirokawa M, Xu B, et al. Cribriform-morular variant of papillary thyroid carcinoma. Report of a case showing morules with peculiar nuclear clearing. Acta Cytol. 2004;48:431–6.CrossRefGoogle Scholar
  10. 10.
    Hirokawa M, Kuma S, Miyauchi A, et al. Morules in cribriform-morular variant of papillary thyroid carcinoma: immunohistochemical characteristics and distinction from squamous metaplasia. APMIS. 2004;112:275–82.CrossRefGoogle Scholar
  11. 11.
    Takada N, Hirokawa M, Ito A, et al. Cytoplasmic lipid accumulation characteristic of the cribriform variant of papillary thyroid carcinoma. Pathobiology. 2017;84:251–7.CrossRefGoogle Scholar
  12. 12.
    Pusztaszeri MP, Auger M, Stelow EB, et al. Papillary thyroid carcinoma, variants, and related tumors. In: Ali S, Cibas E, editors. The Bethesda system for reporting thyroid cytopathology: definitions, criteria, and explanatory notes. 2nd ed. New York, NY: Springer; 2018. p. 149–50.Google Scholar
  13. 13.
    Jung CK, Choi YJ, Lee KY, et al. The cytological, clinical, and pathological features of the cribriform-morular variant of papillary thyroid carcinoma and mutation analysis of CTNNB1 and BRAF genes. Thyroid. 2009;19:905–13.CrossRefGoogle Scholar
  14. 14.
    Boonyaarunnate T, Olson MT, Bishop JA, et al. Cribriform morular variant of papillary thyroid carcinoma: clinical and cytomorphological features on fine-needle aspiration. Acta Cytol. 2013;57:127–33.CrossRefGoogle Scholar
  15. 15.
    Cameselle TJ, Chan JK. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol. 1999;12:400–11.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Ayana Suzuki
    • 1
    Email author
  • Mitsuyoshi Hirokawa
    • 2
  • Nami Takada
    • 3
  1. 1.Department of Clinical LaboratoryKuma HospitalKobeJapan
  2. 2.Department of Diagnostic Pathology and CytologyKuma HospitalKobeJapan
  3. 3.Department of Diagnostic PathologyFaculty of Medicine, Oita UniversityYufuJapan

Personalised recommendations